VITAL KSK HLDGS INC.

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, VITAL KSK HLDGS INC. has already paid €0.19 in dividends. The last payout was in June.

Financials

In the last quarter, VITAL KSK HLDGS INC. had revenue of €869.67m and net profit of €582.74k

(EUR)	September 2026	YoY
Revenue	869.67m	0.66%
Gross profit	66.86m	3.85%
Net profit	582.74k	97.63%
EBITDA	5.96m	85.61%

Fundamentals

Metric	Value
Market capitalization	€371.21m
Number of shares	47.5m
52-week high/low	€9.75 - €7.02
Dividend yield	4.94%
Dividends TTM	€0.38
Next dividend	€0.20
Beta	0.27
P/E ratio	23.42
PEG ratio	-0.33
P/B ratio	0.56
P/S ratio	0.11

Company profile

Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It also engages in the pharmacy and nursing care businesses; transportation business; insurance agent and real estate management businesses; parking business; mail-order business of health-related products; and pharmacy dispensing business. In addition, the company offers medical management consulting services; and manufactures OTC drugs. The company was founded in 2009 and is headquartered in Tokyo, Japan.